Which Is The Best Bet In The Life Insurance Space? #AskBQ
#AskBQ | Expert advice on Cadila Healthcare, REC, TVS Motor, and many more.
.jpg?rect=0%2C81%2C3000%2C1688&auto=format%2Ccompress&w=200)
AskBQ is BloombergQuint’s daily offering where market experts help investors make the right investment choice in the equity market.
In today’s episode, Amar Singh of Angel Broking and Parthiv Shah of Tracom Stock Brokers gave their views on Cadila Healthcare, REC, TVS Motor, and many more.
Watch the full conversation here:
Here are the edited excerpts of the interaction:
G Akshay: I bought 1,000 shares of Cadila Healthcare at Rs 430 apiece with a long-term view. Should I hold or sell?
Amar Singh: The investor can hold his position with a stop loss of below Rs 340.
Deevij Gulati: I bought 500 shares of REC at Rs 130 apiece with a short-term view. What should I do?
Amar Singh: I would recommend that he should exit the stock as soon as possible. If the investor wants to hold, the stop loss should be Rs 113.
Rohit Kumar: I bought 500 shares of Crompton Greaves Consumer at Rs 238 apiece with a long-term view. What should I do?
Parthiv Shah: Ideally, the investor should exit Crompton Greaves and shift their holding to V-Guard.
Arpit Maheshwari: I bought 500 shares of Techno Electric at Rs 374 with a four-year view. Please advise.
Parthiv Shah: There is still some room for downside in this counter. At this stage, I would recommend Kalpataru Power and KEC International in the space as an alternative.
Bharat Bhushan: Which stock among ICICI Prudential, SBI Life and HDFC Standard Life is a better bet with a long-term view?
Parthiv Shah: I would recommend HDFC Life, as its a quality stock despite being more expensive.
Saurabh Pathak: Which stock among Bharat Dynamics, Astra Micro and Bharat Electronics is a better bet with a three-five year view?
Parthiv Shah: I would recommend Bharat Electronics and Hindustan Aeronautical in the space, as both the companies have a fantastic order book, and I doubt if a private player can eat into their share.
Bhabani Shankar Behera: I bought shares of Vakrangee at Rs 258 and HEG at Rs 3,200 with a one-two months view. What should I do?
Amar Singh: The investor can hold his positions in HEG with a stop loss of Rs 3,040, and can book profits at Rs 3,400 levels.
As for Vakrangee, I would not recommend anyone to go in for fresh buys in this stock.
Ravi Gopal: I bought 70 shares of TVS Motor at Rs 300 apiece. What should I do?
Parthiv Shah: The investor can sell at least 50 percent of his holding and invest it in Hero Motocorp instead.
Akshat Maheshwari: I bought 5,000 shares of HCC at Rs 37 apiece with a two-year view. Please advise.
Parthiv Shah: I am more comfortable parking my money in PSP Projects.
Nishant Deshmukh: I bought 500 shares of Waterbase at Rs 260 with a short-term view. What should I do?
Parthiv Shah: I would recommend Avanti Feeds in the space, which has consistently done well.
Sanjeev Kumar: I bought 500 shares of VA Tech Wabag at Rs 730 with a long-term view. Should I average at current levels?
Parthiv Shah: I recommend the investor to hold, wait for the financial results, and then take a call.
Here’s how you can get your queries answered:
- Tweet us your queries using #AskBQ
- WhatsApp us on +91-8291229686
- Call us on 022-45404141
- Email us on askbq@bloombergquint.com
Analysts’ disclosure:
- Both the analysts do not have any financial interests and do not hold any stocks discussed today.
Disclaimer: The commentary on BloombergQuint represents the view of external experts. Investors are advised to consult a certified financial advisor/planner when making any investments. No views shared on a BloombergQuint program or story or conversation should be construed as personal advice.
Quintillion Business Media Pvt. (BloombergQuint) is not responsible for any risk or loss that might occur as a result of using this information in any way, regardless of your interpretation of the advice.
BloombergQuint’s digital and social media platforms provide views of only SEBI registered investment advisors/analysts.